Viyash Scientific (NSE:VIYASH) Other Current Liabilities: ₹1,754 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VIYASH Viyash Scientific Ltd NSE:VIYASH
73 GF Score
Price ₹268.65
GF Value ₹172.52
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Viyash Scientific Other Current Liabilities?

Viyash Scientific NSE:VIYASH -3.03% 73 Other Current Liabilities is ₹1,754 Mil as of Mar. 2026. GuruFocus rates NSE:VIYASH with a GF Score™ of 73/100 and a GF Value™ of ₹172.52 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Viyash Scientific's other current liabilities for the quarter that ended in Mar. 2026 was ₹1,754 Mil.

Viyash Scientific's quarterly other current liabilities declined from Sep. 2025 (₹769 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,754 Mil).

Viyash Scientific's annual other current liabilities declined from Mar. 2024 (₹426 Mil) to Mar. 2025 (₹321 Mil) but then increased from Mar. 2025 (₹321 Mil) to Mar. 2026 (₹1,754 Mil).

Viyash Scientific Other Current Liabilities Related Terms

Viyash Scientific Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Viyash Scientific's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viyash Scientific Other Current Liabilities Chart

Viyash Scientific Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 422.04 446.10 426.02 321.41 1,753.50

Viyash Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 321.41 0.00 768.70 0.00 1,753.50
NSE:VIYASH
73GF Score
Viyash Scientific Ltd NSE:VIYASH
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viyash Scientific Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹1,754 Mil mean?
Viyash Scientific (NSE:VIYASH) has a Other Current Liabilities of ₹1,754 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Viyash Scientific.
Is Viyash Scientific's Other Current Liabilities too high?
Viyash Scientific's current Other Current Liabilities is ₹1,754 Mil. Overall, Viyash Scientific has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viyash Scientific's Other Current Liabilities compare to ZTS and UTHR?
Viyash Scientific's Other Current Liabilities of ₹1,754 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Viyash Scientific. Viyash Scientific's current Other Current Liabilities is ₹1,754 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viyash Scientific stock overvalued right now?
Based on GuruFocus' analysis, Viyash Scientific (NSE:VIYASH) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹172.52, compared to a current price of ₹268.65 — trading 55.7% above its estimated fair value. The current Other Current Liabilities is ₹1,754 Mil. Viyash Scientific's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Viyash Scientific (NSE:VIYASH), the current Other Current Liabilities is ₹1,754 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viyash Scientific (NSE:VIYASH) Overvalued in 2026?

Based on GuruFocus' analysis, Viyash Scientific stock appears to be overvalued. The current stock price of ₹268.65 is trading 55.7% above its estimated GF Value™ of ₹172.52. GuruFocus considers Viyash Scientific to be Significantly Overvalued.

Key valuation signals for NSE:VIYASH:

  • Other Current Liabilities: ₹1,754 Mil
  • GF Value™: ₹172.52 vs. price of ₹268.65 (55.7% above fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the NSE:VIYASH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viyash Scientific Business Description

Other Exchanges 512529:India
Address Road No.6, Kakatiya Hills, 3rd Floor, Srivalli’s Corporate, Plot No. 290, Guttala Begumpet, Jubilee Hills, Madhapur, Survey number 33 34P to 39, Hyderabad, KA, IND, 500033
Viyash Scientific Ltd is a pharmaceutical company with activities spanning formulations, active pharmaceutical ingredients (APIs), and intermediates. It is focused on research and development infrastructure for APIs and formulations. Its product portfolio spans several therapeutic areas, including ARV, cardiovascular, central nervous system, analgesics, antibiotics, antihistamines, diabetes, gastrointestinal, anticoagulants, and oncology.
73GF Score

Get the complete analysis for NSE:VIYASH

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹268.65
Price
₹172.52
GF Value